Dietary salt restriction is an essential constituent of diabetes care in preventing or slowing the development of diabetes complications, and many diabetes management guidelines include recommendations for dietary salt intake. However, descriptions of guidelines for salt intake are sometimes confined to studies of participants without diabetes or small short-term studies of patients with diabetes. However, in response to such situations, recent longitudinal studies of patients with diabetes have reported an association between dietary salt intake and diabetes complications. Thus, this review summarizes important points in the current situation regarding guidelines on salt intake and the latest findings and future issues on dietary salt intake for diabetes care focusing on (i) the current status and issues regarding the leading guidelines for dietary salt intake for diabetes care in various regions worldwide, and (ii) findings on salt intake from recent longitudinal studies of patients with diabetes whose dietary salt intake was restricted.
| INTRODUCTION
Reduction in dietary salt intake is encouraged throughout the world for reducing blood pressure, which is the major cause of cardiovascular disease (CVD).
1 Particularly, consistent dietary salt restriction is emphasized for patients at high risk for arteriosclerosis such as those with diabetes, dyslipidemia, or renal disease. [2] [3] [4] Guidelines for the treatment of diabetes throughout the world include recommendations for restriction of dietary salt intake [4] [5] [6] [7] to prevent or at least slow the development of diabetes complications related to macroangiopathy such as CVD and microangiopathy such as nephropathy, retinopathy, and neuropathy.
However, reports of studies of salt reduction in patients with diabetes have been limited, and guidelines for salt intake were sometimes based on epidemiological studies of participants without diabetes. It is also an issue that there are few studies of dietary interventions that do not focus on only dietary sodium intake but also include sodium reduction as a part of the protocol, although there have been several small short-term studies that targeted patients with diabetes. Additionally, longitudinal studies regarding the relationship between dietary salt intake and the prognosis of diabetes have been particularly sparse. In response to this situation, some follow-up studies were recently reported on the association between dietary salt intake and diabetes complications in patients with type 1 and 2 diabetes. [8] [9] [10] Thus, this review summarizes important points in the current situ- 
| WHAT ARE THE CURRENT STATUS AND ISSUES OF LEADING GUIDELINES FOR DIABETES CARE IN VARIOUS REGIONS IN THE WORLD WITH REGARD TO DIETARY SALT INTAKE?
It is well known that medical nutritional therapy is positioned as an essential constituent in managing glycemic control and controlling the development of diabetes complications. In guidelines for the treatment for diabetes in various countries, medical nutritional therapy is described with an individual chapter, explaining recommendations for macronutrient intake including carbohydrate, protein, and fat and micronutrient intake as typified by salt. studies to develop guidelines. These should include not only existing short-term studies that report the association between dietary salt intake and blood pressure but also follow-up studies that will investigate dietary sodium intake and the incidence of diabetes complications. P<.01). However, no significant difference was observed when analysis was restricted to patients who had HbA1c levels <9.0% (Table 2) .
| WHAT ARE THE FINDINGS
According to previous studies, it is reported that the risk of CVD in patients with type 2 diabetes was associated with an 18% increase for each 1% point increase in HbA1c 26 and that a higher sodium intake tended to be associated with a high incidence of CVD in nondiabetic Regarding the association between dietary salt intake and mortality in patients with type 2 diabetes, a prospective cohort study was also reported from Australia in 2011 10 in addition to that from Japan as described above. 8 Included in the Australian study were 638 patients who attended a single diabetes clinic; they were registered regardless of the presence of preexisting CVD. Baseline dietary salt intake was measured as urinary sodium excretion per day from a 1-day urine collection. Participants were followed up for 10.5 years, and all-cause mortality was identified from medical records and death certificate data. Mean age at baseline was 64 years and 56%
were men. Their clinical condition was poorly controlled, as the mean HbA1c level was 7.8%, 47% were obese, and 85% had hypertension.
Regarding diabetic complications, 45% had previously experienced a cardiovascular event, 33% had diabetic retinopathy, and 45% had micro-or macroalbuminuria. Mean urinary sodium excretion was 184 mmol/d, and the mean estimated dietary salt intake was 10.7 g/d.
There were 175 fatalities from all causes, and 43% of all deaths were caused by CVD during the median follow-up of 9.9 years. After ad- Table 2 ).
Based on the findings described above on the relationship between dietary salt intake and mortality in patients with type 2 diabetes, 8, 10 results of the association between dietary salt intake and mortality were confusing. A possible reason for such inconsistent results might be large differences in the background of patients in each study such as HbA1c, BMI, blood pressure control, and presence or absence of diabetic complications. For instance, in the Australian study, 10 half of the patients had a history of a cardiovascular event and/or albuminuria. In contrast, participants in the study in Japan 8 had good control of diabetes and none had diabetic complications. Another possible reason is the difference in education for salt reduction between Australia and Japan. In Australia, progressive salt reduction policy has been implemented in cooperation with government, nongovernmental organizations, medical institutions, and food industries. 28 Further studies are needed to clarify the association between daily salt intake and mortality risk based on a careful consideration of the characteristics of patients and situation of education for salt reduction.
| CONCLUSION
Dietary salt restriction has been noted as an essential constituent of diabetes care in many guidelines, 4-7 although supportive evidence is apt to depend on studies of participants without diabetes or small short-term studies of patients with diabetes. On the other hand, some longitudinal studies were recently reported regarding the association between dietary salt intake and diabetes complications in patients with diabetes. [8] [9] [10] Based on such situations, this review summarized important points on the current status and issues related to leading guidelines for diabetes care from various countries and findings from recent longitudinal studies for patients with diabetes. Most of the recent longitudinal studies supported current guidelines for diabetes care 8, 9 ; yet an inconsistent result was obtained for the association between dietary salt intake and mortality. 10 Further research that considers ethnic-specific characteristics, intercultural differences, and patients' clinical condition is important in exploring effective medical nutritional therapy and developing guidelines based on firm evidence.
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